Biocidium is a clinical-stage biopharmaceutical company focused on discovering and developing anti-infective and oncology products. Its pipeline centers on novel antibiotics and antifungals for multidrug-resistant infections, while also advancing dermatology and skin cancer programs.
Small molecule therapeutics, anti-infectives, antibiotics, antifungals, oncology, dermatology, and drug development for multidrug-resistant infections.
Novel antibiotic and antifungal candidates, MDR infection programs, skin cancer programs, and discovery platforms spanning infectious disease and dermatology.